QR kód

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases

Background. Bedaquiline is currently a drug of choice in therapy for extensively and multidrug-resistant tuberculosis. It is indicated for children from a 6-year age and young adults as part of a combination chemotherapy, in compliance with the medical council’s (MC) regulation on active extensively...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: A. A. Akzhigitova, T. N. Ignatova, A. К. Konratov, M. В. Теn
Médium: Artigo
Jazyk:Russo
Vydáno: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2022-05-01
Edice:Кубанский научный медицинский вестник
Témata:
On-line přístup:https://ksma.elpub.ru/jour/article/view/2764
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!